Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume:1386.7
2.84
-0.01  (-0.35%)
Announcement & Circular
03-30
2015
APPOINTMENT OF VICE EXECUTIVE CHAIRMAN
03-30
2015
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
03-30
2015
MAJOR TRANSACTION - ACQUISITION OF THE EQUITY INTEREST IN BEIJING JIALIN PHARMACEUTICAL CO., LTD. FULFILLMENT OF PERFORMANCE GUARANTEE
03-30
2015
Annual Results Announcement for the year ended 31 December 2014
03-27
2015
COMPLETION OF PHASE 1 CLINICAL STUDIES OF ANSOFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS (LY03005) IN CHINA
03-23
2015
ANNOUNCEMENT - CLINICAL STUDY OF LY03004 DEMONSTRATES GENERALLY SIMILAR PHARMACOKINETIC AND SAFETY PROFILES IN U.S. PATIENTS TO A MARKETED PRODUCT IN THE SAME DOSAGE FORM
03-18
2015
NOTICE OF BOARD MEETING
03-05
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2015
02-09
2015
CLARIFICATION ANNOUNCEMENT
02-09
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2015
45
46
47
48
49